Financhill
Sell
49

CDLX Quote, Financials, Valuation and Earnings

Last price:
$3.85
Seasonality move :
-6.43%
Day range:
$3.78 - $3.92
52-week range:
$2.89 - $20.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.60x
P/B ratio:
2.82x
Volume:
392.5K
Avg. volume:
703K
1-year change:
-58.69%
Market cap:
$196.7M
Revenue:
$309.2M
EPS (TTM):
-$6.29

Analysts' Opinion

  • Consensus Rating
    Cardlytics has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of --, Cardlytics has an estimated upside of 13.7% from its current price of $3.85.
  • Price Target Downside
    According to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $3.85.

Fair Value

  • According to the consensus of 0 analysts, Cardlytics has 13.7% upside to fair value with a price target of -- per share.

CDLX vs. S&P 500

  • Over the past 5 trading days, Cardlytics has underperformed the S&P 500 by -2.11% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cardlytics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cardlytics revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Cardlytics reported revenues of $67.1M.

Earnings Growth

  • Cardlytics has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cardlytics reported earnings per share of -$2.90.
Enterprise value:
342.9M
EV / Invested capital:
1.21x
Price / LTM sales:
0.60x
EV / EBIT:
--
EV / Revenue:
1.17x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-12.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$127.7M
Return On Assets:
-50.62%
Net Income Margin (TTM):
-93.55%
Return On Equity:
-163.62%
Return On Invested Capital:
-67.37%
Operating Margin:
-25.13%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $302.5M $302.5M $293.5M $79M $67.1M
Gross Profit $113.7M $124.3M $127.7M $35.8M $28.6M
Operating Income -$118.4M -$76.5M -$63.1M -$12.3M -$16.9M
EBITDA -$74.9M -$374.7M -$238M -$15.6M -$135.3M
Diluted EPS -$3.51 -$12.22 -$6.29 -$0.63 -$2.90
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $353.9M $335.5M $249.1M $205.6M $183.3M
Total Assets $389.4M $1.2B $1.1B $634.9M $399.4M
Current Liabilities $58.3M $274.5M $254.9M $179.5M $155.9M
Total Liabilities $239.1M $536M $485.8M $409.6M $329.7M
Total Equity $150.4M $688.6M $580.5M $225.3M $69.7M
Total Debt $171.5M $181.7M $225.7M $257.1M $213.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$41.4M -$16.2M -$8.9M $1.2M $1.4M
Cash From Investing -$16M -$11.8M -$16M -$3.1M -$5.3M
Cash From Financing -$39.6M -$20.3M $1.7M $21K -$388K
Free Cash Flow -$55.1M -$28.1M -$27.4M -$2M -$3.9M
CDLX
Sector
Market Cap
$196.7M
$110M
Price % of 52-Week High
18.86%
66.47%
Dividend Yield
0%
0%
Shareholder Yield
-24.79%
3.39%
1-Year Price Total Return
-55.72%
-16.31%
Beta (5-Year)
1.531
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $3.75
200-day SMA
Sell
Level $7.21
Bollinger Bands (100)
Sell
Level 3.17 - 4.53
Chaikin Money Flow
Buy
Level 31M
20-day SMA
Buy
Level $3.84
Relative Strength Index (RSI14)
Buy
Level 50.56
ADX Line
Buy
Level 16.34
Williams %R
Neutral
Level -43.2749
50-day SMA
Sell
Level $3.94
MACD (12, 26)
Sell
Level -0.04
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 59.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-2.2999)
Sell
CA Score (Annual)
Level (-2.2281)
Buy
Beneish M-Score (Annual)
Level (-3.5889)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (4.6459)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Stock Forecast FAQ

In the current month, CDLX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CDLX average analyst price target in the past 3 months is --.

  • Where Will Cardlytics Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cardlytics share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Cardlytics?

    Analysts are divided on their view about Cardlytics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardlytics is a Sell and believe this share price will drop from its current level to --.

  • What Is Cardlytics's Price Target?

    The price target for Cardlytics over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CDLX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cardlytics is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CDLX?

    You can purchase shares of Cardlytics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardlytics shares.

  • What Is The Cardlytics Share Price Today?

    Cardlytics was last trading at $3.85 per share. This represents the most recent stock quote for Cardlytics. Yesterday, Cardlytics closed at $3.85 per share.

  • How To Buy Cardlytics Stock Online?

    In order to purchase Cardlytics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
60
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock